Global IVD In Cardiology And Neurology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for IVD In Cardiology And Neurology Market is presumed to reach the market size of nearly USD 39.57 Billion by 2032 from USD 16.88 Billion in 2023 with a CAGR of 9.93% under the study period 2024 - 2032.

In vitro diagnostics (IVD) in cardiology and neurology refers to diagnostic tests conducted on samples outside the body to assess heart and neurological conditions. These tests include biomarker measurements, genetic analyses, and imaging studies, aiding in the early detection, monitoring, and treatment planning of cardiovascular and neurological diseases.

MARKET DYNAMICS

The IVD (In Vitro Diagnostics) market in cardiology and neurology is driven by the rising prevalence of cardiovascular and neurological disorders globally. Technological advancements in IVD devices, such as biomarker discovery and molecular diagnostics, enhance diagnostic precision. Increased healthcare expenditures, a growing aging population, and proactive initiatives for preventive healthcare further stimulate market expansion. Additionally, integrating artificial intelligence and data analytics into IVD devices aids in personalized and efficient patient diagnostics. However, market restraints encompass challenges related to regulatory complexities and stringent approval processes for novel diagnostic technologies. Overcoming these restraints requires streamlined regulatory pathways and continued efforts to make advanced IVD technologies more accessible and cost-effective for healthcare providers in the cardiology and neurology market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ivd in cardiology and neurology. The growth and trends of ivd in cardiology and neurology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ivd in cardiology and neurology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments
Reagents & Consumables
Software And Services

By Technology

Immunoassays
Molecular Diagnostics
Hematology
Others

By End-Use

Hospitals
Clinical Laboratories
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the IVD In Cardiology And Neurology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global IVD In Cardiology And Neurology Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the IVD In Cardiology And Neurology market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sysmex Corp., Siemens Healthineers AG, Quest Diagnostics Inc., Abbott, BD, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc.This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112113943

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . IVD IN CARDIOLOGY AND NEUROLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Reagents & Consumables Historic and Forecast Sales by Regions
5.6 Software And Services Historic and Forecast Sales by Regions

6 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Immunoassays Historic and Forecast Sales by Regions
6.5 Molecular Diagnostics Historic and Forecast Sales by Regions
6.6 Hematology Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Clinical Laboratories Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IVD IN CARDIOLOGY AND NEUROLOGY COMPANIES

9.1. Ivd In Cardiology And Neurology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF IVD IN CARDIOLOGY AND NEUROLOGY INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. F. Hoffmann-La Roche Ltd.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Sysmex Corp.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Siemens Healthineers AG
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Quest Diagnostics Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott BD
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Beckman Coulter Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies